0001209191-20-030274.txt : 20200518
0001209191-20-030274.hdr.sgml : 20200518
20200518201659
ACCESSION NUMBER: 0001209191-20-030274
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200514
FILED AS OF DATE: 20200518
DATE AS OF CHANGE: 20200518
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SLACIK CHARLES P
CENTRAL INDEX KEY: 0001204660
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-10961
FILM NUMBER: 20891379
MAIL ADDRESS:
STREET 1: 250 S. KRAEMER BLVD
CITY: BREA
STATE: CA
ZIP: 92821
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: QUIDEL CORP /DE/
CENTRAL INDEX KEY: 0000353569
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 942573850
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9975 SUMMERS RIDGE ROAD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 8585521100
MAIL ADDRESS:
STREET 1: 9975 SUMMERS RIDGE ROAD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: MONOCLONAL ANTIBODIES INC /DE/
DATE OF NAME CHANGE: 19910210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-05-14
0
0000353569
QUIDEL CORP /DE/
QDEL
0001204660
SLACIK CHARLES P
9975 SUMMERS RIDGE ROAD
SAN DIEGO
CA
92121
1
0
0
0
Common Stock
2020-05-14
4
M
0
2100
0.00
A
10803
D
Common Stock
2020-05-15
4
M
0
458
0.00
A
11261
D
Common Stock
2020-05-15
4
M
0
91
0.00
A
11352
D
Restricted Stock Units
2020-05-14
4
M
0
2100
0.00
D
Common Stock
2100
0
D
Restricted Stock Units
2020-05-15
4
M
0
458
0.00
D
Common Stock
458
0
D
Restricted Stock Units
2020-05-15
4
M
0
91
0.00
D
Common Stock
91
0
D
Reflects release of restricted stock units that were previously reported on Form 4.
Reflects release of shares of common stock previous granted pursuant to the Issuer's deferred compensation plan.
Restricted stock units convert into common stock on a one-for-one basis.
On May 14, 2019, the reporting person was granted 2,100 restricted stock units vesting on the first anniversary of the grant date.
On May 15, 2018, the reporting person was granted 458 shares of common stock pursuant to the Issuer's deferred compensation plan, which shares were released on May 15, 2020.
On May 15, 2018, the reporting person was granted 91 shares of common stock pursuant to the Issuer's deferred compensation plan, which shares were released on May 15, 2020.
Robert J. Bujarski, attorney-in-fact for Charles P. Slacik
2020-05-18